Reviewing The Latest Multiple Sclerosis Research
Many doctors and drug analysts say that the disease multiple sclerosis remains an under-treated ailment, with no cure in sight. A handful of drugs on the market only help manage symptoms. This is not good news for people struggling with the debilitative symptoms of MS. Scientists who specialize is multiple sclerosis research have yet to identify exactly what causes the disease and, more importantly, a cure. In this article, we’ll explore the latest in MS research.
Some doctors say the best hope for treatment is early diagnosis and then stopping the progression. Consequently, pharmaceutical companies involved in multiple sclerosis research are trying to develop medications that slow the progression of the disease and delay the onset of symptoms. It’s important to remember that developing safe treatments for multiple sclerosis has been difficult for scientists. Tysabri was pulled from the market in 2005 after three patients in clinical trials contracted a rare brain infection and two patients died. The Food and Drug Administration allowed the drug to enter the market again in 2006 under a restricted distribution system.
MRI multiple sclerosis monitoring is proving to be invaluable. Scientists are now able to see and follow the development of MS lesions in the brain and spinal cord. This is a tremendous aid in the assessment of new therapies and can speed up the process of evaluating new treatments. There are a number of treatments under investigation that may curtail attacks or improve the function of damaged nerve fibers. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models.
More On: Advances In Multiple Sclerosis Research
Technorati Tags: multiple sclerosis, multiple sclerosis research, advances in multiple sclerosis research
Quickly bookmark Reviewing The Latest Multiple Sclerosis Research at:
Leave a Reply
You must be logged in to post a comment.
